Outcomes of CD19 chimeric antigen receptor T cell followed by haploidentical hematopoietic stem-cell transplantation in relapsed/refractory B-cell acute lymphoblastic leukemia with IKZF1 deletion

被引：0
|
作者：
Fang Ni
Elaine Tan Su Yin
Linghui Zhou
Houli Zhao
Yi Luo
Jimin Shi
Yongxian Hu
He Huang
机构：
[1] the First Affiliated Hospital,Bone Marrow Transplantation Center
[2] Zhejiang University School of Medicine,Liangzhu Laboratory
[3] Zhejiang University Medical Center,Institute of Hematology
[4] Zhejiang University,undefined
[5] Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy,undefined
来源：
Bone Marrow Transplantation | 2022年 / 57卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：326 / 328
页数：2
相关论文
共 50 条
  • [1] Outcomes of CD19 chimeric antigen receptor T cell followed by haploidentical hematopoietic stem-cell transplantation in relapsed/refractory B-cell acute lymphoblastic leukemia with IKZF1 deletion
    Ni, Fang
    Yin, Elaine Tan Su
    Zhou, Linghui
    Zhao, Houli
    Luo, Yi
    Shi, Jimin
    Hu, Yongxian
    Huang, He
    [J]. BONE MARROW TRANSPLANTATION, 2022, 57 (02) : 326 - 328
  • [2] CD19 chimeric antigen receptor-T cells as bridging therapy to allogeneic hematopoietic cell transplantation improves outcome in patients with refractory/relapsed B-cell acute lymphoblastic leukemia
    Liu, Jie
    Xu, Mengyuan
    Zhang, Xiaoqian
    Zhang, Zhuo
    Zhong, Tao
    Yu, Hongjuan
    Fu, Yueyue
    Meng, Hongbin
    Feng, Jiawei
    Zou, Xindi
    Han, Xueying
    Kang, Liqing
    Yu, Lei
    Li, Limin
    [J]. HELIYON, 2024, 10 (13)
  • [3] CD19-CAR-T Therapy Followed By Allogeneic Hematopoietic Stem Cell Transplantation in Refractory/Relapsed and High Risk B-Cell Acute Lymphoblastic Leukemia
    Zhao, Yanli
    Zhang, Jianping
    Liu, Deyan
    Xiong, Min
    Wei, Zhijie
    Sun, Ruijuan
    Zhou, Jiarui
    Lu, Yue
    Cao, Xingyu
    Yang, Junfang
    Zhang, Xian
    Wang, Hui
    Liu, Hongxing
    Lu, Peihua
    Lu, Daopei
    [J]. BLOOD, 2018, 132
  • [4] HLA-matched and HLA-haploidentical allogeneic CD19-directed chimeric antigen receptor T-cell infusions are feasible in relapsed or refractory B-cell acute lymphoblastic leukemia before hematopoietic stem cell transplantation
    Jin, Xin
    Cao, Yaqing
    Wang, Luqiao
    Sun, Rui
    Cheng, Lin
    He, Xiaoyuan
    Xiao, Xia
    Jiang, Yili
    Li, Qing
    Zhang, Huan
    Lu, Wenyi
    Lyu, Cuicui
    Jiang, Yanyu
    Meng, Juanxia
    Zhao, Mingfeng
    [J]. LEUKEMIA, 2020, 34 (03) : 909 - 913
  • [5] HLA-matched and HLA-haploidentical allogeneic CD19-directed chimeric antigen receptor T-cell infusions are feasible in relapsed or refractory B-cell acute lymphoblastic leukemia before hematopoietic stem cell transplantation
    Xin Jin
    Yaqing Cao
    Luqiao Wang
    Rui Sun
    Lin Cheng
    Xiaoyuan He
    Xia Xiao
    Yili Jiang
    Qing Li
    Huan Zhang
    Wenyi Lu
    Cuicui Lyu
    Yanyu Jiang
    Juanxia Meng
    Mingfeng Zhao
    [J]. Leukemia, 2020, 34 : 909 - 913
  • [6] Hematopoietic stem cell transplantation and chimeric antigen receptor T cell for relapsed or refractory diffuse large B-cell lymphoma
    Wang, Tao
    Gao, Lei
    Wang, Yujie
    Zhu, Wenjun
    Xu, Lili
    Wang, Yang
    Yue, Wenqin
    Tang, Gusheng
    Chen, Li
    Chen, Jie
    Zhang, Weiping
    Yu, Xuejun
    Feng, Dongge
    Yang, Jianmin
    [J]. IMMUNOTHERAPY, 2020, 12 (13) : 997 - 1006
  • [7] Consolidative allogeneic hematopoietic stem cell transplantation after chimeric antigen receptor T-cell therapy for relapsed/refractory B-cell acute lymphoblastic leukemia: who? When? Why?
    Jiang, Huiwen
    Hu, Yu
    Mei, Heng
    [J]. BIOMARKER RESEARCH, 2020, 8 (01)
  • [8] Consolidative allogeneic hematopoietic stem cell transplantation after chimeric antigen receptor T-cell therapy for relapsed/refractory B-cell acute lymphoblastic leukemia: who? When? Why?
    Huiwen Jiang
    Yu Hu
    Heng Mei
    [J]. Biomarker Research, 8
  • [9] CD19 Chimeric Antigen Receptor T Cell Therapy for the Treatment of B Cell Lineage Acute Lymphoblastic Leukemia
    Chen, Runzhe
    Song, Xiao-Tong
    Chen, Baoan
    [J]. DISCOVERY MEDICINE, 2015, 20 (110) : 185 - 190
  • [10] Immunotherapy with Autologous Anti-CD19 Chimeric Antigen Receptor T Cells Followed By Allogeneic Hematopoietic Stem Cell Transplantation Has Remarkably Improved Leukemia-Free Survival in Refractory/Relapsed B-Cell Acute Lymphoblastic Leukemia
    Zhao, Yan-Li
    Wu, Tong
    Liu, De-Yan
    Zhang, Jian-Ping
    Wei, Zhi-Jie
    Lu, Yue
    Cao, Xing-Yu
    Xiong, Min
    Zhou, Jia-Rui
    Sun, Rui-Juan
    Ji, Shu-Quan
    Tong, Chun-Rong
    Lu, Dao-Pei
    [J]. BLOOD, 2016, 128 (22)
12345